Clinical Trial Update: Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immune response to the influenza vaccine in multiple sclerosis patients treated with teriflunomide; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• AUBAGIO (TERIFLUNOMIDE)
• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2013-02-26